1. Home
  2. KBH vs SRRK Comparison

KBH vs SRRK Comparison

Compare KBH & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KBH
  • SRRK
  • Stock Information
  • Founded
  • KBH 1957
  • SRRK 2012
  • Country
  • KBH United States
  • SRRK United States
  • Employees
  • KBH N/A
  • SRRK N/A
  • Industry
  • KBH Homebuilding
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KBH Consumer Discretionary
  • SRRK Health Care
  • Exchange
  • KBH Nasdaq
  • SRRK Nasdaq
  • Market Cap
  • KBH 3.8B
  • SRRK 3.2B
  • IPO Year
  • KBH 1987
  • SRRK 2018
  • Fundamental
  • Price
  • KBH $57.23
  • SRRK $36.36
  • Analyst Decision
  • KBH Buy
  • SRRK Strong Buy
  • Analyst Count
  • KBH 12
  • SRRK 7
  • Target Price
  • KBH $67.04
  • SRRK $42.17
  • AVG Volume (30 Days)
  • KBH 1.5M
  • SRRK 1.2M
  • Earning Date
  • KBH 09-23-2025
  • SRRK 08-06-2025
  • Dividend Yield
  • KBH 1.75%
  • SRRK N/A
  • EPS Growth
  • KBH 0.49
  • SRRK N/A
  • EPS
  • KBH 7.59
  • SRRK N/A
  • Revenue
  • KBH $6,673,869,000.00
  • SRRK N/A
  • Revenue This Year
  • KBH N/A
  • SRRK N/A
  • Revenue Next Year
  • KBH N/A
  • SRRK $1,960.31
  • P/E Ratio
  • KBH $7.54
  • SRRK N/A
  • Revenue Growth
  • KBH 3.65
  • SRRK N/A
  • 52 Week Low
  • KBH $48.90
  • SRRK $6.76
  • 52 Week High
  • KBH $89.70
  • SRRK $46.98
  • Technical
  • Relative Strength Index (RSI)
  • KBH 56.50
  • SRRK 46.15
  • Support Level
  • KBH $54.22
  • SRRK $36.96
  • Resistance Level
  • KBH $57.48
  • SRRK $39.13
  • Average True Range (ATR)
  • KBH 1.79
  • SRRK 1.69
  • MACD
  • KBH -0.05
  • SRRK -0.59
  • Stochastic Oscillator
  • KBH 63.12
  • SRRK 9.08

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Share on Social Networks: